{"title":"干眼症药物治疗的科学背景和基础。","authors":"Jeffrey P Gilbard","doi":"10.1016/j.ohc.2005.07.003","DOIUrl":null,"url":null,"abstract":"<p><p>The ability to diagnose and treat dry eye has improved dramatically over the last decade as understanding of disease mechanisms and pathology has improved. The ability to screen patients for dry eye before ophthalmic plastics procedures has improved, and the ability to manage and treat dry eye in patients after surgery also has improved.</p>","PeriodicalId":82231,"journal":{"name":"Ophthalmology clinics of North America","volume":"18 4","pages":"475-84, v"},"PeriodicalIF":0.0000,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"The scientific context and basis of the pharmacologic management of dry eyes.\",\"authors\":\"Jeffrey P Gilbard\",\"doi\":\"10.1016/j.ohc.2005.07.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The ability to diagnose and treat dry eye has improved dramatically over the last decade as understanding of disease mechanisms and pathology has improved. The ability to screen patients for dry eye before ophthalmic plastics procedures has improved, and the ability to manage and treat dry eye in patients after surgery also has improved.</p>\",\"PeriodicalId\":82231,\"journal\":{\"name\":\"Ophthalmology clinics of North America\",\"volume\":\"18 4\",\"pages\":\"475-84, v\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmology clinics of North America\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ohc.2005.07.003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology clinics of North America","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ohc.2005.07.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The scientific context and basis of the pharmacologic management of dry eyes.
The ability to diagnose and treat dry eye has improved dramatically over the last decade as understanding of disease mechanisms and pathology has improved. The ability to screen patients for dry eye before ophthalmic plastics procedures has improved, and the ability to manage and treat dry eye in patients after surgery also has improved.